CAR Stock Recent News

After Hertz's massive Ackman rally, this setup presented a good pair trade to long Avis and short Hertz. I bet this pair trade still has legs. Hertz is experiencing growing interest expenses that impact bottom-line performance, while Avis is actively reducing debt. Both companies are executing a fleet rotation strategy to enhance operational efficiency; however, Avis is well-positioned to benefit from this strategy as compared to Hertz.

NEW YORK , July 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avis Budget Group, Inc. (NASDAQ: CAR)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Avis caused the company to misrepresent or fail to disclose that (i) Avis Budget crafted and implemented a plan to significantly accelerate its fleet rotation in the fourth quarter of 2024; (ii) the foregoing acceleration shortened the useful life of the majority of the Company's vehicles in the Americas segment, thereby reducing their recoverable value; (iii) as a result, Avis Budget would be forced to recognize billions of dollars in impairment charges and incur substantial losses; (iv) all the foregoing was likely to, and did, have a significant negative impact on the Company's financial results; (v) accordingly, Avis Budget's financial and/or business prospects were overstated; and (vi) as

The meme-stock frenzy is seemingly making a comeback in 2025 as investors once again chase unprofitable companies for their latest bets.

SAN DIEGO--(BUSINESS WIRE)-- #invivoscribe--Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Through this collaboration, LabPMM (Invivoscribe's global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented.

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avis Budget Group, Inc. (NYSE: CAR) breached their fiduciary duties to shareholders.

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Avis Budget Group, Inc. (NASDAQ:CAR) on behalf of long-term stockholders following a class action complaint that was filed against Avis on April 25, 2025 with a Class Period from February 16, 2024 and February 10, 2025. Our investigation concerns whether the board of directors of Avis have breached their fiduciary duties to the company.

With their stocks trading near 52-week highs, Uber Technologies (UBER) and Avis Budget Group (CAR) helped lead Tuesday's broader market rally.

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit.

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR) and certain of its officers.